Zurich Cantonal Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.1M | Sell |
465,371
-32,178
| -6% | -$2.7M | 0.08% | 194 |
|
|
2026
Q1 | $39.8M | Buy |
+497,549
| New | +$41M | 0.09% | 192 |
|
|
2025
Q4 | – | Sell |
-489,089
| Closed | -$40.1M | – | 2883 |
|
|
2025
Q3 | $38M | Buy |
489,089
+143,412
| +41% | +$11.2M | 0.09% | 191 |
|
|
2025
Q2 | $27M | Buy |
345,677
+91,513
| +36% | +$6.83M | 0.07% | 264 |
|
|
2025
Q1 | $18.4M | Sell |
254,164
-253,605
| -50% | -$18.2M | 0.05% | 323 |
|
|
2024
Q4 | $37.6M | Buy |
507,769
+29,351
| +6% | +$2.05M | 0.11% | 159 |
|
|
2024
Q3 | $31.6M | Buy |
478,418
+40,348
| +9% | +$2.93M | 0.09% | 189 |
|
|
2024
Q2 | $40.5M | Buy |
438,070
+183,047
| +72% | +$16.2M | 0.13% | 129 |
|
|
2024
Q1 | $24.4M | Sell |
255,023
-78,656
| -24% | -$6.61M | 0.09% | 214 |
|
|
2023
Q4 | $25.4M | Sell |
333,679
-76,392
| -19% | -$5.32M | 0.1% | 186 |
|
|
2023
Q3 | $28.4M | Buy |
410,071
+179,583
| +78% | +$14.4M | 0.13% | 142 |
|
|
2023
Q2 | $21.7M | Sell |
230,488
-128,312
| -36% | -$11.2M | 0.1% | 196 |
|
|
2023
Q1 | $29.7M | Sell |
358,800
-70,336
| -16% | -$5.53M | 0.14% | 131 |
|
|
2022
Q4 | $32M | Buy |
429,136
+96,510
| +29% | +$7.44M | 0.17% | 119 |
|
|
2022
Q3 | $27.5M | Buy |
332,626
+22,813
| +7% | +$2.2M | 0.16% | 121 |
|
|
2022
Q2 | $29.5M | Buy |
309,813
+12,870
| +4% | +$1.33M | 0.17% | 108 |
|
|
2022
Q1 | $35M | Buy |
296,943
+10,118
| +4% | +$1.14M | 0.17% | 111 |
|
|
2021
Q4 | $37.2M | Buy |
286,825
+26,618
| +10% | +$3.1M | 0.18% | 113 |
|
|
2021
Q3 | $29.5M | Buy |
260,207
+70,726
| +37% | +$8.07M | 0.16% | 124 |
|
|
2021
Q2 | $19.6M | Sell |
189,481
-8,636
| -4% | -$814K | 0.11% | 184 |
|
|
2021
Q1 | $16.6M | Buy |
198,117
+8,622
| +5% | +$729K | 0.1% | 189 |
|
|
2020
Q4 | $17.3M | Buy |
189,495
+1,121
| +0.6% | +$93K | 0.11% | 177 |
|
|
2020
Q3 | $15M | Buy |
188,374
+33,389
| +22% | +$2.61M | 0.11% | 172 |
|
|
2020
Q2 | $10.7M | Sell |
154,985
-5,917
| -4% | -$421K | 0.09% | 214 |
|
|
2020
Q1 | $10.1M | Buy |
160,902
+18,816
| +13% | +$1.36M | 0.09% | 216 |
|
|
2019
Q4 | $11M | Sell |
142,086
-60
| -0% | -$4.68K | 0.09% | 258 |
|
|
2019
Q3 | $10.4M | Buy |
142,146
+4,338
| +3% | +$305K | 0.09% | 256 |
|
|
2019
Q2 | $8.49M | Buy |
137,808
+2,238
| +2% | +$135K | 0.07% | 300 |
|
|
2019
Q1 | $8.65M | Buy |
135,570
+1,413
| +1% | +$80.6K | 0.08% | 285 |
|
|
2018
Q4 | $6.85M | Sell |
134,157
-2,925
| -2% | -$148K | 0.07% | 305 |
|
|
2018
Q3 | $7.96M | Sell |
137,082
-2,886
| -2% | -$141K | 0.07% | 325 |
|
|
2018
Q2 | $6.79M | Hold |
139,968
| – | – | 0.06% | 346 |
|
|
2018
Q1 | $6.51M | Buy |
139,968
+2,943
| +2% | +$128K | 0.06% | 367 |
|
|
2017
Q4 | $5.15M | Sell |
137,025
-19,431
| -12% | -$713K | 0.05% | 403 |
|
|
2017
Q3 | $5.7M | Buy |
156,456
+2,397
| +2% | +$91.4K | 0.05% | 380 |
|
|
2017
Q2 | $6.07M | Sell |
154,059
-6,000
| -4% | -$219K | 0.06% | 348 |
|
|
2017
Q1 | $5.02M | Sell |
160,059
-238,290
| -60% | -$7.46M | 0.05% | 395 |
|
|
2016
Q4 | $12.4M | Sell |
398,349
-214,311
| -35% | -$6.94M | 0.13% | 173 |
|
|
2016
Q3 | $24.6M | Sell |
612,660
-1,272
| -0.2% | -$47.9K | 0.26% | 87 |
|
|
2016
Q2 | $20.4M | Buy |
613,932
+169,506
| +38% | +$5.8M | 0.27% | 87 |
|
|
2016
Q1 | $13.1M | Sell |
444,426
-12,657
| -3% | -$349K | 0.17% | 134 |
|
|
2015
Q4 | $12M | Buy |
457,083
+276,417
| +153% | +$7.18M | 0.15% | 142 |
|
|
2015
Q3 | $4.28M | Sell |
180,666
-1,656
| -0.9% | -$40K | 0.06% | 310 |
|
|
2015
Q2 | $4.33M | Buy |
182,322
+111,936
| +159% | +$2.53M | 0.06% | 320 |
|
|
2015
Q1 | $1.67M | Buy |
70,386
+4,842
| +7% | +$109K | 0.02% | 582 |
|
|
2014
Q4 | $1.39M | Buy |
65,544
+16,740
| +34% | +$336K | 0.04% | 461 |
|
|
2014
Q3 | $831K | Sell |
48,804
-87,000
| -64% | -$1.37M | 0.03% | 567 |
|
|
2014
Q2 | $1.94M | Buy |
135,804
+6,936
| +5% | +$94K | 0.06% | 397 |
|
|
2014
Q1 | $1.59M | Sell |
128,868
-153,000
| -54% | -$1.77M | 0.05% | 410 |
|
|
2013
Q4 | $3.09M | Buy |
281,868
+942
| +0.3% | +$10.6K | 0.1% | 227 |
|
|
2013
Q3 | $3.26M | Hold |
280,926
| – | – | 0.11% | 200 |
|
|
2013
Q2 | $3.15M | Buy |
+280,926
| New | +$3.33M | 0.11% | 185 |
|
Other funds holding EW
Zurich Cantonal Bank's EW Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its Edwards Lifesciences (EW) stake by 6.5% in Q2 2026, selling an estimated $2.7M and leaving 465,371 shares worth $42.1M. The position accounts for 0.08% of the portfolio, ranked #194.
Zurich Cantonal Bank first reported a position in EW in Q2 2013 and has held it in 52 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Zurich Cantonal Bank held 465,371 shares of Edwards Lifesciences worth $42.1M as of Q2 2026.
- Zurich Cantonal Bank sold 32,178 Edwards Lifesciences shares in Q2 2026, an estimated $2.7M.
- Edwards Lifesciences made up 0.08% of Zurich Cantonal Bank's portfolio in Q2 2026, its #194 holding.
- Zurich Cantonal Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.